FDA 483 - Sturgis Dairy - June 01, 2022

Sturgis Dairy received a Form 483 with four observations following an inspection from April to June 2022. The observations primarily concern the extralabel use of animal drugs leading to violative residues, administration of prohibited drugs, and significant deficiencies in treatment and animal identification record-keeping. These issues indicate serious non-compliance with regulations regarding drug use in food-producing animals and traceability.